Harvard Bioscience
HBIO
#10520
Rank
C$52.46 M
Marketcap
C$11.53
Share price
-1.32%
Change (1 day)
1,908.61%
Change (1 year)

Earnings for Harvard Bioscience (HBIO)

Earnings in 2026 (TTM): -C$14.68 Million

According to Harvard Bioscience's latest financial reports the company's current earnings are C$87.8 Million. In 2025 the company made an earning of -C$80.37 Million a decrease over its 2024 earnings that were of -C$16.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harvard Bioscience from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$14.68 Million-81.74%
2025 -C$80.37 Million391.95%
2024 -C$16.34 Million356.38%
2023 -C$3.58 Million-72.15%
2022 -C$12.86 Million6456.43%
2021 -C$0.2 Million-98.08%
2020 -C$10.22 Million32.53%
2019 -C$7.71 Million-31.01%
2018 -C$11.17 Million243.9%
2017 -C$3.25 Million-24.66%
2016 -C$4.32 Million-14.69%
2015 -C$5.06 Million-181.68%
2014 C$6.18 M-9.97%
2013 C$6.87 M120%
2012 C$3.12 M-50.9%
2011 C$6.36 M-52.51%
2010 C$13.39 M-2.53%
2009 C$13.74 M28.26%
2008 C$10.71 M-20.05%
2007 C$13.39 M13.96%
2006 C$11.75 M17.59%
2005 C$9.99 M57.37%
2004 C$6.35 M-37.31%
2003 C$10.13 M208.03%
2002 C$3.29 M-168.71%
2001 -C$4.79 Million-66.89%
2000 -C$14.47 Million